Israel makes cancer treatment breakthrough with genomic profiling

A collaboration agreement that will promote personalized cancer treatment based on genomic profiling for cancer patients has been signed by the Hadassah-University Medical Center in Jerusalem’s Ein Kerem, the Roche-Israel pharmaceutical company and Roche’s affiliate in Massachusetts, Foundation Medicine. It will be the first such integrated model to be offered in Israel. For the first […]

Continue Reading